| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |